Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24

Nvidia notching another day of losses, but the broader markets aren’t taking it too hard. How investors are handling the semi slide. Plus A big jump for one biopharma stock as Alnylam delivers promising new heart drug results. What the CEO had to say about the data, and the impact it could have on the space.

Fast Money Disclaimer